Naveen Yalamanchi

Naveen is a close partner to Rod in the firm’s research and asset selection division and is responsible for the firm’s medical technology investments. His team researches and analyzes medical device, diagnostics, and digital health companies and emerging technologies for opportunities to add value and accelerate their impact on patient lives.

Prior to RTW, Naveen was vice president and co-portfolio manager at Calamos Arista Partners. Before joining Calamos, he held various healthcare investment roles at Millennium Management and Davidson Kempner Capital Management, where he worked with Rod.

Naveen serves on the board of directors of Rocket Pharmaceuticals. He graduated Phi Beta Kappa with a BS in Biology from MIT, received his MD from Stanford University, and completed his surgical internship at UCLA Medical Center.